Est. 2016 · Gimhae, Gyeongsangnam-do

Enrollment velocity and milestone charts your steering committee can read in ten minutes

We compile site-level enrollment counts, screen-failure ratios, and protocol milestone dates into brass-edged report folios for sponsors running oncology, rare disease, and vaccine studies in Korea and neighboring markets.

Submit a study brief See milestone ledger samples
Clinical research coordinator reviewing printed enrollment charts at a desk
Week 14 · Screen-to-randomize ratio, three active sites

What arrives on your desk

Each reporting cycle, you receive a bound folio—not a login screen—with enrollment curves by site, cumulative randomization against target, and a milestone table keyed to your protocol schedule. Figures are annotated with the assumptions behind them: last patient visit dates, screen-failure definitions, and any country-specific regulatory holds.

Our analysts sit with your clinical operations lead before the first delivery to agree on chart conventions, color keys for site tiers, and the cadence that matches your DSMB or internal review rhythm.

Report commissions

Three recurring deliverables sponsors request most often during enrollment-heavy phases.

All report types

How a reporting cycle runs

  1. 01

    Data receipt and reconciliation

    You send EDC exports, site activation logs, or CTMS extracts. We reconcile row counts against your prior cycle and flag discrepancies before charting.

  2. 02

    Chart assembly and annotation

    Enrollment curves, waterfall diagrams for screen failures, and milestone Gantt strips are drawn to the conventions agreed at kickoff. Every figure carries a footnote citing the source file and extraction date.

  3. 03

    Review call and folio dispatch

    A 30-minute walkthrough with your ops lead precedes PDF delivery and optional printed copies couriered to your Gimhae-area office or sponsor HQ.

"The Week 22 enrollment folio showed our Busan site lagging before our CRA noticed it in the field. The chart footnotes explained exactly which screen-failure codes drove the gap—something our previous vendor never documented. I did wish the first delivery had included Korean site names alongside English, but they corrected that by cycle two."

Dr. Min-jae Han Clinical Operations Director, Phase III NSCLC study · Seoul

Ready to commission your first enrollment folio?

Send your protocol ID, active site list, and preferred reporting cadence. We respond within two business days with a scope outline and fee estimate.

Request a brief